Professor George Haber is the Chief Executive Officer (CEO) of Cleveland Clinic Abu Dhabi. Professor Haber leads a team of over 6,000 caregivers, focusing on strategic growth, innovation, and excellence in high-acuity care. His leadership is instrumental in driving innovation and implementing tech-enabled health solutions while transforming the traditional healthcare landscape. In addition to focusing on his role as CEO, Professor Haber will continue to practice as a urologist specializing in robotic surgery.

Prior to his appointment as CEO of Cleveland Clinic Abu Dhabi, Professor Haber served as Chairman of the Glickman Urologic and Kidney Institute at Cleveland Clinic in Ohio. In this role, he significantly expanded patient services, enhanced surgical outcomes, and elevated the institute to the #1 program in the world per Newsweek ranking. In over two decades of experience within the Cleveland Clinic global network, Professor Haber has cemented his reputation as a surgical innovator. He led his surgical teams in performing the first ever scar-free removal of a healthy kidney for transplant in Europe, the first large series of scar-free kidney and prostate surgery performed through the belly button, the first ever robotic kidney transplant in the UAE, and multiple firsts at Cleveland Clinic including first robotic intracorporeal urinary diversion, robotic auto transplant and robotic Level 3 IVC thrombectomy.

Professor Haber completed his executive education at Wharton and Harvard Business Schools.